Patients presenting with acute malignant colonic obstruction often undergo emergency surgery, although this is associated with significant mortality and morbidity. An alternative approach is to use a ...

The high incidence of colorectal cancer and the high number of patients presenting with a bowel obstruction (7–29% of patients with colorectal cancer) requires the development of novel techniques to ...

The largest randomised trial to examine the effectiveness of two surgical interventions for treating acute malignant bowel obstruction, a common symptom of patients with colorectal cancer, suggests ...

Association of genetic variants in plastin family genes with tumor recurrence in stage II/III colon cancer. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not ...

<0> Cook MedicalCaitlin Wenz, 812-339-2235, ext. 4245Specialist, Public Relations,orRacepoint Group, Inc.Sally Bain, 781-487-4647 </0> The U.S. Food and Drug Administration (FDA) has granted 510(k) ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Cook Medical has announced it has received FDA clearance for its Evolution colonic controlled-release stent, according to a news release. The new stent is designed to be used to palliate uncomfortable ...